LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Operating income, 2025
- $41M
- 5-year CAGR
- +1.8%
- 10-year CAGR
- +4.1%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $41M | — |
| 2024 | −$23M | — |
| 2023 | $12M | +293.2% |
| 2022 | $3.0M | −97.1% |
| 2021 | $104M | +176.9% |
| 2020 | $38M | −95.4% |
| 2019 | $807M | +392.9% |
| 2018 | $164M | +140.5% |
| 2017 | $68M | +55.1% |
| 2016 | $44M | +60.6% |
| 2015 | $27M | +39.2% |
| 2014 | $20M | +31.3% |
| 2013 | $15M | +7,642.5% |
| 2012 | $193K | — |
| 2011 | −$878K | — |
| 2010 | −$29M | — |
| 2009 | −$10.0M | — |